Article
Cross‐species chemogenomic profiling reveals evolutionarily conserved drug mode of action
21 Dec 2010
Abstract excerpt
We present a cross-species chemogenomic screening platform using libraries of haploid deletion mutants from two yeast species, Saccharomyces cerevisiae and Schizosaccharomyces pombe. We screened a set of compounds of known and unknown mode of action (MoA) and derived quantitative drug scores (or D-scores), identifying mutants that are either sensitive or resistant to particular compounds. We found that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
